The Ramsay (ASX:RHC) share price lifted 8% last time the company reported

Let's take a look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is enjoying a decent day of trading this Wednesday. The ASX 200 is currently up 0.16% to 7,515 points at the time of writing. However, in what might be some trepidation about it's earnings report tomorrow, the Ramsay Health Care Limited (ASX: RHC) share price is not enjoying the same treatment. Ramsay shares are currently trading at the rather unfortunate share price of  $66.66, down 0.48% for the day.

So as I just mentioned, Ramsay is scheduled to report its full-year earnings for FY2021 tomorrow morning. But while we wait with bated breath for these numbers, let's check out what the Ramsay Health Care share price did last time the company had an appointment with its investors.

So Ramsay reported its half-year earnings back in February of this year, 25 February to be precise.

Here's a summary of what the company reported at the time:

  • Revenues of $5.9 billion, a 6.6% fall over the previous corresponding period (pcp).
  • Statutory net profit of $226 million, a 12.5% drop over the pcp.
  • Diluted earnings per share (EPS) came in at 96.9 cents, a decline of 21.1% over the pcp
  • Earnings before interest and tax (EBIT) of $583.8 million, a 4.2% slump.
  • An interim dividend of 48.5 cents per share, fully franked, 21.1% lower than Ramsay's previous interim payout.
share price up

Image source: Getty Images

How did the Ramsay Health Care share price respond?

Despite these numbers showing a significant hit from the coronavirus outbreak, investors responded enthusiastically to these earnings back in February. As we covered at the time, investors sent Ramsay shares up around 8% in the first few hours of trading following this release. As it stands today, Ramsay shares are around 5.5% higher than the day before this report became public 6 months ago.

At the current Ramsay share price, the company has a market capitalisation of $15.32 billion, a price-to-earnings (P/E) ratio of 62.96 and a dividend yield of 0.72%.

This company is up 6.88% year to date in 2021 so far, but is only up 1.07% over the past 12 months. Disappointingly for its investors, the Ramsay share price is also down close to 12% over the past 5 years.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »